Discover trends, market shifts, and competitive outlooks for the extended-release drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Projected Market Size and Growth Rates for the Extended-Release Drugs Market From 2025 To 2029?#_x000D_

The market size of extended-release drugs has seen a substantial growth surge lately. The prediction for its expansion is from $63.11 billion in 2024 to $70.28 billion in 2025, representing a compound annual growth rate (CAGR) of 11.4%. The previous period’s growth can be linked to enhancements in patient compliance, the prevalence of chronic diseases, increased efficiency, strategic patent protection, and biodegradable implants._x000D_

_x000D_

The market size for extended-release medications is predicted to experience considerable expansion in the upcoming years. The anticipated growth is to reach $113.05 billion by 2029, with a compound annual growth rate (CAGR) of 12.6%. This anticipated growth in the forecast period is due to several factors such as personalized medicine strategies, development of drugs focused on the patient, increasing occurrence of lifestyle-related diseases, drug repositioning, and worldwide accessibility to extended-release treatments. Significant trends during the forecast period encompass pharmaceutical innovation, advancements in medicine delivery systems, progress in nanotechnology, the application of 3D printing in drug formulations, utilization of artificial intelligence, and environmental sustainability._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp_x000D_

_x000D_

#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theExtended-Release Drugs Market?#_x000D_

The rise in chronic illnesses is anticipated to stimulate the expansion of the extended-release drug market in the future. Chronic diseases are those that persist for a year or more and require ongoing medical attention, limit daily activities, or both. Heart disease, cancer, obesity, and diabetes are some examples. Extended-release drug delivery mechanisms aim to maintain a fairly steady concentration of medicine in the body over an extended period. This aids in maintaining a steady therapeutic effect and preventing the variations in drug levels that can happen with immediate-release drugs. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, estimated in January 2023 that by 2050, the population of individuals aged 50 and above suffering from at least one chronic disease would skyrocket by 99.5%, reaching 142.66 million. Thus, the escalating prevalence of chronic diseases is propelling the extended-release drug market’s growth._x000D_

_x000D_

#Which Segments in the Extended-Release Drugs Offer the Most Growth?#_x000D_

The extended-release drugs market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Sustained Release Drug, Controlled Release Drug_x000D_

2) By Mode: Over-The-Counter, Prescription_x000D_

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores_x000D_

_x000D_

Subsegments:_x000D_

1) By Sustained Release Drug: Matrix Systems, Coating Systems_x000D_

2) By Controlled Release Drug: Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12675&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theExtended-Release Drugs Market?# Market?#_x000D_

North America was the largest region in the extended-release drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Extended-Release Drugs Industry?#_x000D_

Advancements in product design and creation is an emerging trend gaining traction in the market for extended-release drugs. To maintain their market position, leading companies in this sector are focusing on developing innovative products. For instance, in July 2022, Zydus Pharmaceuticals (USA) Inc., an American generic pharmaceutical producer, unveiled its Topiramate extended-release capsules designed for epilepsy treatment. The US Food and Drug Administration (USFDA) had granted prior approval for the company to market Topiramate extended-release capsules, USP 25 mg, 50 mg, and 100 mg. The company was the first in the nation to receive final approval for, and launch, Topiramate extended-release capsules. These capsules have received approval for treating individuals experiencing either partial onset or primary generalized tonic-clinic seizure._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Extended-Release Drugs Market?#_x000D_

Extended-release drugs are a dosage form made to release the medication over a longer time, at a predetermined rate, duration, and location, in a controlled manner. The drug can be taken less frequently than the immediate release form, and patients may take 1 to 2 doses each day instead of 3 to 4._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12675_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model